Intracoronary cangrelor administration-assisted primary percutaneous coronary intervention in a patient with essential thrombocythemia and recurrent ST-segment elevation myocardial infarction

J Cardiovasc Med (Hagerstown). 2020 Oct;21(10):825-828. doi: 10.2459/JCM.0000000000001006.

Authors

Alfonso Ielasi¹, Marco Loffi², Andrea Buono¹, Giuseppe De Blasio³, Maurizio Tespili¹

Affiliations

¹ Clinical and Interventional Cardiology Unit, Sant'Ambrogio Cardio-Thoracic Center GSD, Milan.
² Cardiology Unit, Azienda Socio Sanitaria Territoriale (ASST) di Cremona, Cremona.
³ Cardiology Unit, IRCCS Istituto Ortopedico Galeazzi GSD, Milan, Italy.

PMID: 32740411
DOI: 10.2459/JCM.0000000000001006

No abstract available

Publication types

Case Reports

MeSH terms

Adenosine Monophosphate / administration & dosage
Adenosine Monophosphate / analogs & derivatives*
Adult
Angioplasty, Balloon, Coronary* / instrumentation
Coronary Thrombosis / diagnostic imaging
Coronary Thrombosis / etiology
Coronary Thrombosis / physiopathology
Coronary Thrombosis / therapy*
Drug-Eluting Stents
Humans
Hydroxyurea / therapeutic use
Infusions, Intravenous
Male
Platelet Aggregation Inhibitors / administration & dosage*
Purinergic P2Y Receptor Antagonists / administration & dosage*
Recurrence
ST Elevation Myocardial Infarction / diagnostic imaging
ST Elevation Myocardial Infarction / etiology
ST Elevation Myocardial Infarction / physiopathology
ST Elevation Myocardial Infarction / therapy*
Thrombocythemia, Essential / complications*
Thrombocythemia, Essential / diagnosis
Thrombocythemia, Essential / drug therapy
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Adenosine Monophosphate
cangrelor
Hydroxyurea